Results 221 to 228 of about 4,730,461 (228)

Previous treatment influences fingolimod efficacy in relapsing–remitting multiple sclerosis: results from an observational study

Current Medical Research and Opinion, 2014
Paolo Immovilli, Erica Curti, Diana Ferraro   +2 more
exaly  

Emergence of thalamic magnetization transfer ratio abnormality in early relapsing—remitting multiple sclerosis

Multiple Sclerosis Journal, 2005
Daniel Altmann, Alan J. Thompson, Gareth J. Barker   +2 more
exaly  

Efficacy and safety of rituximab for relapsing-remitting multiple sclerosis: A systematic review and meta-analysis

Autoimmunity Reviews, 2019
Chuan Qin, Long-Jun Wu, Zhouping Tang
exaly  

Trends in annualized relapse rates in relapsing–remitting multiple sclerosis and consequences for clinical trial design

Multiple Sclerosis Journal, 2011
Tim Friede, Sebastian Straube, Richard Nicholas   +2 more
exaly  

Efficacy and safety of BG-12 (dimethyl fumarate) and other disease-modifying therapies for the treatment of relapsing–remitting multiple sclerosis: a systematic review and mixed treatment comparison

Current Medical Research and Opinion, 2014
Robert J. Fox, Michael Hutchinson, Eva Havrdová   +2 more
exaly  

Impact of exposure to interferon beta-1a on outcomes in patients with relapsing–remitting multiple sclerosis: exploratory analyses from the PRISMS long-term follow-up study

Therapeutic Advances in Neurological Disorders, 2011
Anthony Traboulsee, Bernard Uitdehaag
exaly  

Effect of high-dose vitamin D3 supplementation on antibody responses against Epstein-Barr virus in relapsing-remitting multiple sclerosis.

Multiple Sclerosis Journal, 2017
Øivind Torkildsen, Trygve Holmøy, Tomas Olsson   +2 more
exaly  

Advances in and Algorithms for the Treatment of Relapsing-Remitting Multiple Sclerosis

Neurotherapeutics, 2015
Hans-Peter Hartung, Orhan Aktaş, Jens Ingwersen   +2 more
exaly